Filing notes
A U.S. filing or press release is long, and the friendliest sentence is usually first. We read the document and set the same numbers next to the size of the company. These notes are that record.
Each note has the exchange and ticker, the document title and time, the source link, the numbers in the document, and why a promotional sentence is not the same as a change in the structure. When the document states a share count or a cash figure, the note sets it next to the size of the company. When it does not, the note says so. The method is written once, in the guides.
These notes are not a solicitation and they do not forecast the price. They record what the document says and how large that number is for the company.
SEC filings
A reading of the EDGAR document (8-K, 424B5, 10-Q, and others), with the numbers in the document set next to the size of the company.
- NASDAQ · RROther filing
RR annual-meeting filing: reading director elections and auditor approval from the yes-vote ratio
The note reads the 2026 annual meeting results of Richtech Robotics from the vote counts. Two directors received 95.9% and 98.9% in favor, auditor approval was 99.8%, and all three items had the same 406,256,772 votes cast.
Form 8-K (Item 5.02, 5.07) · 2026-10-02 17:25:13 ET
- NASDAQ · TNXPOther filing
TNXP 8-K: how to read a notice that a generic maker challenged the patent
Tonix disclosed a Paragraph IV patent-challenge notice from Dr. Reddy's on the TONMYA generic. The note uses the dates in the filing to separate what the notice starts from what is still undecided.
Form 8-K (Item 8.01 Other Events) · 2026-10-02 17:20:11 ET
- NASDAQ · HSCSOther filing
HSCS eighth amendment to a $500,000 note: the 2021 maturity moves to the earlier of the merger close and January 29, 2027
HeartSciences extended the maturity of a $500,000 note borrowed in 2020. The original maturity was September 30, 2021. This time it is the earlier of two business days after the Fortitude Mining Holdings merger closes and January 29, 2027.
Form 8-K (Item 1.01, 2.03) · 2026-10-02 17:15:13 ET
- NASDAQ · DFLIOther filing
DFLI loan waiver: what the eighth amendment and a deferred preferred dividend say
Dragonfly Energy received a one-month waiver of a minimum-liquidity covenant and agreed to pay 6 of the 8 percent Series B preferred cash dividend one month later. The note copies the dates and the rates as written.
Form 8-K (Item 1.01, 2.03, 3.03) · 2026-10-02 17:00:40 ET
- NASDAQ · NNEM&A
NNE asset purchase: the dollar amount in the “vertical integration” release is about 2% of the company's cash
Nano Nuclear Energy agreed to buy NRC permits and technical materials for a uranium processing facility that has not been built, for $9.5M in cash and $4M in stock. The note reads the tone of the sentences next to the size of the amount.
Form 8-K (Item 1.01, 3.02, 7.01) + EX-99.1 보도자료 · 2026-10-02 16:30:35 ET
- NASDAQ · QUBTOther filing
QUBT investor presentation: reading $1.3 billion in cash next to $9.2 million in first-half revenue
Quantum Computing Inc. filed an updated investor presentation on an 8-K. The note sets the company's own figures next to each other: a $1.9B market cap, $1.3B in cash and investments, and $9.2M of first-half revenue.
Form 8-K (Item 7.01 Regulation FD) + EX-99.1 투자자 발표자료 · 2026-10-02 16:26:12 ET
- NASDAQ · BIOAClinical and regulatory
BIOA Phase 2 start filing: what “first patient dosed” does and does not say
BioAge Labs said it dosed the first participant in the Phase 2 diabetic macular edema trial QUELL-DME and published the design. The note reads the design figures: about 180 people, three arms, and 12 weeks of dosing.
Form 8-K (Item 8.01 Other Events) · 2026-10-02 16:15:14 ET
- NASDAQ · VERIOffering
VERI registered direct: 20 million shares at $0.75, 37% below the prior close, with proceeds to repay convertible notes
Veritone filed a registered direct to sell 20 million shares at $0.75. The gross is $15.0M and the net is $13.8M, and the document says the money goes to convertible-note repayment and restructuring and to working capital. The new shares are 19.7% of shares already outstanding.
Form 424B5 (Prospectus Supplement) · 2026-10-01 17:01:31 ET
- NASDAQ · PYXSOffering
PYXS offering: about 43% new shares versus the count before the deal, with a warrant attached again
Pyxis Oncology announced an offering of about $110M. The new shares are about 43% of the share count before the offering, and a warrant with a $3.50 exercise price is attached separately.
Form 424B5 (Prospectus Supplement) · 2026-10-01 09:30:39 ET
- NASDAQ · VHCATM program
VHC ATM agreement: a company with 4.2 million shares outstanding opened a $19.1 million sales cap
VirnetX signed an ATM agreement with Titan Partners to sell up to $19,135,717 into the market over time. At the document's assumed price of $10.32, that is 44.2% of 4,196,009 shares outstanding.
Form 424B5 (Prospectus Supplement) · 2026-10-01 08:51:12 ET
- NASDAQ · FWDIOffering
FWDI registered direct: 4.3% of shares outstanding at $8.00, with warrants already outstanding that are larger
Forward Industries is selling 3,125,000 shares to one institutional investor at $8.00 to raise $25M. The new shares are 4.3% of shares outstanding, while the footnote's 25,759,100 warrants and pre-funded warrants are 35.2%.
Form 424B5 (Prospectus Supplement) · 2026-09-24 11:36:06 ET
- NASDAQ · AEHLOffering
AEHL $6M convertible note: a moving conversion price, and 12,000,000 registered shares are 73% of shares outstanding
Antelope Enterprise is issuing a $6M convertible note to one investor. The conversion price keeps moving, at 80% of the lowest VWAP of the last three trading days, and the 12,000,000 registered conversion shares are 73.1% of 16,409,359 shares outstanding.
Form 424B5 (Prospectus Supplement) · 2026-09-15 16:45:37 ET
Press releases
A reading of a wire release next to the same company's filing, to see how the share count, the financing, or the contract changed. Wording that exists only in the release is kept apart from terms that exist only in the filing.
- NASDAQ · NNBROffering
NNBR PIPE press release: a structure that issues 16.1 million new shares to retire preferred stock
NN, Inc. said it would sell 16.1M shares at $3.30 to raise $50M net and redeem all of the Series D preferred. An 8-K from two days earlier raised authorized shares from 90M to 180M, and the note checks that this deal depends on that increase.
보도자료 + Form 8-K (Item 5.03, 5.07) · 2026-10-02 08:00 ET
- NASDAQ · HYPDOther filing
HYPD press release: the $8.6M debt payoff is in the filing; the buyback is not yet
Hyperion DeFi said it bought 240,124 shares and repaid about $8.6M of the Avenue Capital loan in full. The loan payoff and $14.5M of cash are in the 8-K. The buyback share count is not.
보도자료 + Form 8-K (Item 1.02, 2.02, 7.01, 8.01) · 2026-10-02 08:00 ET
- NASDAQ · AEHLATM program
AEHL $100M ATM press release: the figure missing from the release is 70.7% of shares outstanding
AEHL announced an ATM program of up to $100M. The release does not state the fee or the share count. The 424B5 filed the same day states 11,641,443 shares at an assumed $8.59, which is 70.7% of shares outstanding.
보도자료 + Form 424B5 (ATM 프로스펙터스 보충서) · 2026-10-01 16:08 ET
- NASDAQ · SGMTOffering
SGMT $115M offering press release: the word “or” hides 11,500,020 shares
Sagimet said it would raise $115.0M by selling 8,750,010 common shares “or” 2,750,010 pre-funded warrants. Matching the 424B5 total of $114,999,925 shows the two pieces add up to 11,500,020 shares.
보도자료 + Form 424B5 (프로스펙터스 보충서) · 2026-09-30 06:19 ET
- NASDAQ · FWDIOffering
FWDI press release “SOL per share”: how many shares go in the denominator
Forward Industries said a $25M registered direct would raise both the SOL holding and SOL per share. The 424B5 states that the same company's warrants and pre-funded warrants are 25,759,100 shares, 35.2% of shares outstanding.
보도자료 + Form 424B5 (프로스펙터스 보충서) · 2026-09-23 08:00 ET